Furthermore, in cancer cells, it has been observed that the presence of the low-activity dimeric form of PKM2 promotes the conversion of pyruvate to lactate [10] and that the increased levels of lactic acid detected in cancer patients are related to rapid tumor growth and high levels of metastases [11]. Here, PKM is linked to cancer.